ACCV ACCV
Company Profile ↓Company Overview
ACCV (ACCV) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 130.2% per year over the last five years.
Revenue has grown at a 146.9% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $447.82M (+146.9% YoY); net profit $21.66M.
- Trailing 12 Months Year-on-year growth — revenue +146.9%, earnings +130.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 146.9%, profit CAGR 130.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 146.94% |
| 1 Year: | 146.94% |
Compounded Profit Growth
| 5 Years: | 130.15% |
| 1 Year: | 130.15% |
Stock Price Performance
| 1 Year: | -1.28% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 146.9% over 5 years.
- Profit CAGR of 130.2% over 5 years.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 57.82M | 100.81M | 255.99M | 181.47M |
| Cost of Revenue | 36.53M | 73.80M | 188.23M | 133.07M |
| Gross Profit | 21.29M | 27.01M | 67.76M | 48.39M |
| Operating Expenses | 23.99M | 14.70M | 36.67M | 39.68M |
| Operating Income | -2.71M | 12.31M | 31.09M | 8.71M |
| EBITDA | 4.95M | 13.39M | 38.99M | 15.63M |
| Interest Expense | 5.11M | 5.32M | 7.09M | 8.19M |
| Pretax Income | -8.23M | -168.00K | 22.23M | -1.96M |
| Tax Provision | 136.00K | 173.00K | 460.00K | 484.00K |
| Net Income | -8.37M | -341.00K | 21.61M | -2.78M |
| Diluted EPS | - | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 181.35M | 447.82M |
| Cost of Revenue | 122.49M | 303.12M |
| Gross Profit | 58.86M | 144.70M |
| Operating Expenses | 40.40M | 100.39M |
| Operating Income | 18.46M | 44.30M |
| EBITDA | 27.16M | 79.57M |
| Interest Expense | 9.44M | 22.08M |
| Pretax Income | 9.73M | 22.68M |
| Tax Provision | 326.00K | 928.00K |
| Net Income | 9.41M | 21.66M |
| Diluted EPS | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Total Assets | 189.72M | 722.95M |
| Current Assets | 82.56M | 210.66M |
| Cash & Equivalents | 10.93M | 16.27M |
| Inventory | 9.78M | 45.28M |
| Receivables | 46.50M | 82.30M |
| Total Liabilities | 149.29M | 415.79M |
| Current Liabilities | 53.65M | 113.81M |
| Long Term Debt | 81.81M | 269.87M |
| Total Debt | 94.14M | 297.17M |
| Total Equity | 40.43M | 301.24M |
| Shares Outstanding | - | - |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | 10.75M | -7.22M |
| Investing Cash Flow | -4.27M | -442.53M |
| Financing Cash Flow | -2.74M | 466.01M |
| Capital Expenditure | -4.27M | -9.16M |
| Free Cash Flow | 6.47M | -16.39M |
| Net Change in Cash | 3.73M | 16.27M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Gross Margin % | 32.5% | 32.3% |
| Operating Margin % | 10.2% | 9.9% |
| Net Margin % | 5.2% | 4.8% |
| ROE % | 23.3% | 7.2% |
| ROCE % | 13.6% | 7.3% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ACCV
Accelevation shares fall 2.5% as data center firm debuts at $17.55
Investing.com -- Shares of Accelevation Holdings Corp (NASDAQ:ACCV) slipped 2.5% in their public market debut on Wednesday after the data center infrastructure manufacturer and its private equity backer raised $540 million in an initial pub…
Accelevation Announces Pricing of Initial Public Offering
MIAMISBURG, Ohio, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Accelevation Holdings Corp. (“Accelevation”) today announced the pricing of its initial public offering of 30,000,000 shares of its Class A common stock at a public offering price of $18.…
Accelevation Launches Roadshow for Proposed Initial Public Offering
MIAMISBURG, Ohio, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Accelevation Holdings Corp. (“Accelevation”) today announced the launch of the roadshow for its proposed initial public offering of 30,000,000 shares of its Class A common stock, includin…
AI Infrastructure Firm Accelevation Prices IPO Below Target Range
Accelevation is set to make its trading debut on Wednesday after the artificial intelligence infrast
ACCV — Frequently Asked Questions
What is the current share price of ACCV?
As of 2026-10-02 16:24 PDT, ACCV trades at $17.72 on NASDAQ/NYSE. Its 52-week range is $16.58 to $17.95.
What is the return on equity (ROE) of ACCV?
ACCV has a return on equity (ROE) of 7.19%. Its return on capital employed (ROCE) is 7.35%.
Is ACCV a good stock to buy?
This page provides a data-driven analysis of ACCV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.